novel therapy
IBD NeurIMM
tissue healing
targeted therapy
novel therapeutic approach
effective therapy
Nature
immune-cell mediated tissue damage
tissue protective immune response
enteric glial cells
intestinal type
glial cell-derived immunomodulator
intestinal homeostasis
inflammatory disorders
innate lymphoid cells
Inflammatory Bowel Disease
ILC3s
Henrique Veiga-Fernandes
ERC CoG grant
cancer
potential
improved outcomes
technical viability
team of
GliaInnateSensing
gastroenteritis
axis
Neuroimmune activation
use
major implications
patients
Ibiza et
discovery
addition